Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Reduvo
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Comment by SamV21on Sep 12, 2022 12:41pm
200 Views
Post# 34956955

RE:RE:Reduvo

RE:RE:Reduvo https://ir.tetrabiopharma.com/newsroom/press-releases/news-details/2020/Tetra-Bio-Pharma-Files-New-Drug-Submission-for-REDUVOTM-in-Canada/default.aspx

According to Tetra and Guy we would be marketing Reduvo in 2021 and have 80 million in revenue from Reduvo in 2022 , I guess that was to keep us all by our phones as 2020 was going to be the break out year , NO ONE BELIEVES A WORD THAT GUY SAYS ANY MORE after investors bought stock in his dream any where from 1.00 down based on GUY PROMISING REVENUE FROM PRODUCT AND NOT HIM SELLING IT OFF TO KEEP HIS SALARY GOING , WHY IS  GUY NOT BUYING SHARES OF TETRA ? NO HE SOLD 5 MILLION OF HIS SHARES TO APHRIA FOR 1.00 A SHARE , SMART MOVE MR. CEO, SHAREHOLDERS SCAMMED OUT OF MILLIONS ON DEAD END DEALS AND PROMISES ! 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities